Venetoclax in Combination with Decitabine for Relapsed T-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Cell Transplant

Long-term disease-free survival in adults with T-cell acute lymphoblastic leukemia (T-ALL) remains poor, particularly after relapse, with few available salvage options. Preclinical data suggest that inhibition of the antiapoptotic protein BCL-2 (B-cell lymphoma 2) either alone or in combination with...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Case Rep Hematol
Päätekijät: Rahmat, Leena T., Nguyen, Anna, Abdulhaq, Haifaa, Prakash, Sonam, Logan, Aaron C., Mannis, Gabriel N.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Hindawi 2018
Aiheet:
Case Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6129347/
https://ncbi.nlm.nih.gov/pubmed/30225152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/6092646
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia